Farms.com Home   News

Fertilizer Prices To Drop In Summer

Producers can expect lower fertilizer prices later this year, but the president and senior economist with NPK Fertilizer Advisory Services says prices will move higher during seeding.

"We're expecting a bump in prices as we go into what is the heaviest use period of the year, but once we get through that we expect prices to come under pressure and drop down through the summer," says David Asbridge. "It's a good possibility that 2013 prices could be even lower than they are now."

"When you have high prices you tend to bring more production capacity on, and that's what we're seeing," he says. "We're seeing a lot of phosphate expansion come on in Saudi Arabia. Potash capacity is growing here in Canada, as well as in Russia. So we're looking at situation where there's a lot of capacity coming on stream."

"We're looking at prices across the board - nitrogen, phosphate and potash - to go down this summer," he says.

But before that, Asbridge says prices will peak in spring. He says producers and retailers have been reluctant to buy fertilizer this winter.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.